Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population.

MLA

Kawuma, Aida N., et al. “Population Pharmacokinetics of Tenofovir given as Either Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide in an African Population.” CPT: Pharmacometrics & Systems Pharmacology, vol. 12, no. 6, June 2023, pp. 821–30. EBSCOhost, https://doi.org/10.1002/psp4.12955.

APA

Kawuma, A. N., Wasmann, R. E., Sinxadi, P., Sokhela, S. M., Chandiwana, N., Venter, W. D. F., Wiesner, L., Maartens, G., & Denti, P. (2023). Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population. CPT: Pharmacometrics & Systems Pharmacology, 12(6), 821–830. https://doi.org/10.1002/psp4.12955

Chicago

Kawuma, Aida N., Roeland E. Wasmann, Phumla Sinxadi, Simiso M. Sokhela, Nomathemba Chandiwana, Willem D. F. Venter, Lubbe Wiesner, Gary Maartens, and Paolo Denti. 2023. “Population Pharmacokinetics of Tenofovir given as Either Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide in an African Population.” CPT: Pharmacometrics & Systems Pharmacology 12 (6): 821–30. doi:10.1002/psp4.12955.